Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 341
Filter
2.
Rev. bras. cir. cardiovasc ; 35(5): 741-756, Sept.-Oct. 2020. tab, graf
Article in English | SES-SP, LILACS, SES-SP | ID: biblio-1137341

ABSTRACT

Abstract Introduction: The aim of this article is to study the efficacy and safety of cardiac shock wave therapy (CSWT) in the treatment of coronary heart disease (CAD). Methods: A comprehensive search of electronic databases and a manual search of conference papers and abstracts were performed until September 30, 2018. The studies using RevMan 5.3 and STATA 14.0 softwares were reviewed, and meta-analyses were performed on 13 indicators, such as a six-min walking distance test (6MWT), New York Heart Association (NYHA) functional class, Seattle Angina Questionnaire (SAQ) score, angina class (Canadian Cardiology Society [CCS]), etc. Results: A total of 26 articles were included. The total patient population was 855, of which 781 patients were treated with CSWT. Meta-analyses indicated that 6MWT (mean difference [MD] 75.64, 95% confidence interval [CI] 49.03, 102.25, P<0.00001) and NYHA (MD -0.70, 95% CI -0.92) in the CSWT group were comparable to those in the conventional revascularization group (MD -0.70, 95% CI -0.92, -0.49, P<0.00001). SAQ (MD 10.75, 95% CI 6.66, 14.83, P<0.00001), CCS (MD -0.99, 95% CI -1.13, -0.84, P<0.00001), nitrate dosage (MD -1.84, 95% CI -2.77, -1.12, P<0.00001), LVEF (MD 3.77, 95% CI 2.17, 5.37, P<0.00001), and SSS (MD -4.29, 95% CI -5.61, -2.96, P<0.00001), SRS (MD -2.90, 95% CI -4.85, -0.95, P=0.004), and the exercise test (standard mean difference 0.57, 95% CI 0.12, 1.02, P=0.01) all showed significant differences. Conclusion: CSWT may offer beneficial effects to patients with CAD, but more large-scale clinical studies are needed to further verify its therapeutic effect.


Subject(s)
Humans , Male , Coronary Disease/therapy , Extracorporeal Shockwave Therapy , Canada , Angiotensin-Converting Enzyme Inhibitors , Cohort Studies , Treatment Outcome , High-Energy Shock Waves , Angiotensin Receptor Antagonists , Percutaneous Coronary Intervention
3.
Prensa méd. argent ; 106(5): 328-338, 20200000. ilus, fig, tab
Article in English | LILACS, BINACIS | ID: biblio-1367938

ABSTRACT

Provisional bifurcation percutaneous coronary intervention (PCI) is recommended over two stent strategy but with the risk of side branch (SB) compromise. Prediction SB compromise is crucial for optimizing of the procedure outcome. Neglecting the proximal bifurcation angle (BA), the distal BA was presented as a reliable predictor of SB compromise supposing that the main vessel is always a straight vessel. However, its impact on the fate of side branch is debated. This study aims to compare between of the corrected BA, the sum of proximal and distal BAs, and the distal BA in terms of prediction of SB compromise. This prospective cohort study was conducted in Zagazig university hospitals in the duration between March 2019 and March 2020, and involved 185 patients who underwent provisional bifurcation PCI. Patients were divided according to the corrected BA into two groups; straight bifurcation model group which involved 73 patients with corrected BA = 180º, and wide bifurcation model group which involved 112 patients with corrected BA > 180 º. Compared to the wide bifurcation model, the incidence of SB compromise was substantially higher in the straight bifurcation model (52.1% vs. 15.2%; P < 0.001). The corrected BA had a better area under the curve compared to the distal BA with statistically significant difference (0.711 vs. 0.580; P = 0.023). Multivariate analysis demonstrated that the corrected BA was among the independent predictors of SB compromise. The study concluded that the corrected BA could be a novel strong predictor of SB compromise after provisional bifurcation PCI for future verification.


Subject(s)
Coronary Artery Disease/surgery , Stents , Multivariate Analysis , Prospective Studies , Cohort Studies , Coronary Disease/therapy , Percutaneous Coronary Intervention
5.
Rev. Méd. Clín. Condes ; 31(1): 21-27, ene.-feb. 2020.
Article in Spanish | LILACS | ID: biblio-1223317

ABSTRACT

Las enfermedades cardiovasculares son muy frecuentes en la población anciana (pacientes mayores de 75 años). El enfrentamiento y manejo de ellas es distinto al indicado en pacientes jóvenes. Son escasos los estudios que incluyen población mayor de 75 años, con evidencia acerca de las diferencias que existen en la respuesta terapéutica en comparación al paciente joven. El anciano tiene mayor fragilidad y múltiples comorbilidades, con reserva cardiaca disminuida, lo que obliga a un manejo integral y acucioso. Los cambios propios de la edad repercuten tanto en riñón, cerebro, hígado, musculatura y corazón, lo que los hace pacientes más proclives a presentar complicaciones de la terapia farmacológica o intervencional. El objetivo de este artículo es resumir las recomendaciones sobre el manejo de las cardiopatías más frecuentes en el anciano, incluyendo insuficiencia cardiaca crónica, cardiopatía coronaria, hipertensión arterial, estenosis aórtica valvular y fibrilación auricular no valvular.


Cardiovascular diseases are very common in the elderly population, and their management is different. There are few studies that include population older than 75 years, with little evidence about the differences in the therapeutic response compared to the young patient. The elderly have greater fragility and multiple comorbidities, with diminished cardiac reserve, which requires a comprehensive and careful management. Changes due to advanced age, in kidney, brain, liver and musculature (among others), make them more vulnerable to complications of the pharmacological or interventional treatment. The objective of this article is to summarize the recommendations on the management of the most frequent heart diseases in the elderly, including chronic heart failure, coronary heart disease, arterial hypertension, valvular aortic stenosis, and non-valvular atrial fibrillation.


Subject(s)
Humans , Aged , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/therapy , Aortic Valve Stenosis , Pacemaker, Artificial , Arrhythmias, Cardiac , Atrial Fibrillation , Death, Sudden, Cardiac , Coronary Disease/diagnosis , Coronary Disease/therapy , Defibrillators , Heart Failure/diagnosis , Heart Failure/therapy , Hypertension/diagnosis , Hypertension/therapy
6.
Arch. cardiol. Méx ; 89(4): 308-314, Oct.-Dec. 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1149088

ABSTRACT

Resumen Antecedentes: La reserva de flujo fraccional (FFR) es una herramienta con evidencia demostrada para guiar las angioplastias coronarias. El reembolso por los sistemas de cobertura de salud es parcial o nulo a pesar de frecuentemente diferir la angioplastia. Nuestro objetivo fue determinar el beneficio económico de la utilización del FFR en la evaluación de lesiones intermedias, y evaluar asimismo puntos finales clínicos en el seguimiento a un año. Métodos: Estudio observacional prospectivo que incluyó una cohorte de pacientes consecutivos con lesiones coronarias intermedias, evaluadas con FFR, entre abril de 2013 y marzo de 2016. Para el análisis económico se evaluaron los recursos específicos utilizados para la realización del procedimiento. Se analizaron puntos finales clínicos (muerte cardiovascular, revascularización de la arteria objetivo e infarto agudo de miocardio) durante la internación y en el seguimiento a un año Resultados: Se incluyeron 222 lesiones en 151 pacientes consecutivos. Se registró FFR positivo en el 26.1% de las lesiones evaluadas. Se estimó que sin la utilización de FFR, 126 pacientes hubieran sido tratados con angioplastia transluminal coronaria y 25 con cirugía de revascularización miocárdica. El costo estimado con la utilización de FFR fue US$ 891,290.08, mientras que sin el mismo hubiera sido de US$ 1,557,352. Esto implicó un ahorro del 43% de los gastos. Se observaron una muerte de origen cardiovascular y dos reinternaciones en el grupo FFR positivo en el seguimiento a un año. Conclusiones: La revascularización de lesiones intermedias guiada por FFR resultó en un beneficio económico al reducir los costos generales sin resultar clínicamente perjudicial.


Abstract Background: Fractional flow reserve (FFR) is a proven technology for guiding percutaneous coronary intervention, but it is not reimbursed despite the fact that it frequently allows to defer revascularization. Our goal was to determine the economic benefit of FFR on intermediate lesions, as well as the clinical endpoints at 1 year follow up. Methods: Observational prospective study that included consecutive patients with intermediate lesions evaluated with FFR between April 2013 and March 2016. For the economic analysis we evaluated the specific resources used during the procedure. Clinical endpoints including cardiovascular death, target lesion revascularization and acute myocardial infarction, were followed up over a one-year period. Results: FFR was performed on 222 lesions in 151 consecutive patients. FFR was positive in 26.1% of the assessed lesions. The estimated total cost using FFR was US$ 891,290.08 while cost estimate without FFR was US$ 1,557,352, meaning 43% in cost savings. There was one cardiovascular death and two readmissions during follow up in the positive FFR group. Conclusions: FFR guided revascularization on intermediate coronary lesions resulted in an economic benefit by reducing overall costs without harming clinical outcomes.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Coronary Disease/therapy , Fractional Flow Reserve, Myocardial , Percutaneous Coronary Intervention/methods , Prospective Studies , Follow-Up Studies , Treatment Outcome , Cost-Benefit Analysis , Percutaneous Coronary Intervention/economics
8.
Int. j. cardiovasc. sci. (Impr.) ; 29(4): f:262-l:269, jul.-ago. 2016. tab
Article in Portuguese | LILACS | ID: biblio-831823

ABSTRACT

Fundamentos: A revascularização do miocárdio na doença triarterial e de tronco da coronária esquerda (TCE) pode ser realizada por intervenção coronariana percutânea (ICP) ou cirurgia de revascularização do miocárdio (CRM). O estudo SYNTAX demonstrou resultados clínicos equivalentes em pacientes de baixa a moderada complexidade anatômica submetidos a CRM ou ICP. Objetivos: Avaliar a incidência de eventos cardiovasculares e taxa de nova revascularização coronariana em pacientes com lesão de TCE e triarterial submetidos à ICP. Métodos: Estudo de coorte observacional não randomizado que avaliou pacientes com doença coronariana triarterial ou de TCE submetidos à ICP com stent farmacológico no período de junho de 2013 a maio de 2015 no Hospital SOS Cardio de Florianópolis. Foram relatados dados basais, características anatômicas principais e desfechos clínicos durante a fase intra-hospitalar e durante seguimento de 12 meses. Resultados: Foram avaliados 46 pacientes com idade média de 69,9 anos. No momento basal, 39,1% apresentavam diabetes mellitus, 19,6% eram tabagistas, 78,3% eram dislipidêmicos, 10,9% apresentavam disfunção renal crônica e 15,2% disfunção ventricular moderada a severa. Quanto ao número de artérias acometidas, 24% eram triarteriais e 76% apresentavam lesão em TCE. Durante o período intra-hospitalar, ocorreu uma taxa de 4,34% de infarto agudo do miocárdio sem supradesnível de ST. Durante esse período, não foi necessária reintervenção e não ocorreram óbitos. No seguimento de 12 meses, a mortalidade por causa cardiovascular foi de 4,35%. A taxa de nova revascularização por CRM foi de 4,3% e por angioplastia foi de 2,2%. Conclusão: Ocorreram baixas taxas de eventos cardiovasculares, indicando que a ICP pode ser uma alternativa aceitável em casos selecionados


Background: Myocardial revascularization in triple-vessel and left main coronary artery (LMCA) diseases can be performed by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The SYNTAX trial demonstrated equivalent clinical results in patients with low to moderate anatomical complexity undergoing CABG or PCI. Objectives: To evaluate the incidence of cardiovascular events and rates of new myocardial revascularization in patients with LMCA and triple-vessel lesions undergoing PCI. Methods: Nonrandomized, observational cohort study that evaluated patients with triple-vessel or LMCA diseases undergoing PCI with drug-eluting stent in the period from June 2013 to May 2015 at the Hospital SOS Cardio in Florianópolis. Baseline data, main anatomical features, and clinical outcomes were reported during the in-hospital phase and during a 12-month follow-up. Results: In total, 46 patients with a mean age of 69.9 years were evaluated. At baseline, 39.1% had diabetes mellitus, 19.6% were smokers, 78.3% had dyslipidemia, 10.9% had chronic renal dysfunction, and 15.2% had moderate to severe ventricular dysfunction. As regards the number of arteries affected, 24% had triple-vessel disease and 76% had lesions in the LMCA. During the in-hospital period, there was a 4.34% rate of acute myocardial infarction without ST elevation. During this period, reintervention was not required and no deaths occurred. In the 12-month follow-up, mortality from cardiovascular causes was 4.35%. The rate of new revascularization was 4.3% by CABG and 2.2% by angioplasty. Conclusion: The rates of cardiovascular events were low, indicating that PCI may be an acceptable alternative in selected cases


Subject(s)
Humans , Male , Female , Aged , Coronary Disease/diagnosis , Coronary Disease/therapy , Coronary Vessels , Coronary Vessels/physiopathology , Myocardial Revascularization/methods , Percutaneous Coronary Intervention/methods , Cardiac Catheterization , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/therapy , Heart Ventricles , Observational Studies as Topic , Risk Factors , Stents , Treatment Outcome
11.
In. Kalil Filho, Roberto; Fuster, Valetim; Albuquerque, Cícero Piva de. Medicina cardiovascular reduzindo o impacto das doenças / Cardiovascular medicine reducing the impact of diseases. São Paulo, Atheneu, 2016. p.239-251.
Monography in Portuguese | LILACS | ID: biblio-971539
12.
Rev. bras. cardiol. invasiva ; 23(4): f:279-l:281, out.-dez. 2015. ilus
Article in Portuguese | LILACS | ID: biblio-846619

ABSTRACT

A dissecção coronária espontânea é uma entidade rara e, por conseguinte, de etiologia, fisiopatologia e tratamento ainda não estabelecidos. Acomete, em geral, mulheres jovens, sem os clássicos fatores de risco cardiovascular, comumente ao longo do ciclo gravídico-puerperal. Vários fatores influenciam na estratégia de tratamento, como quadro clínico, status hemodinâmico, topografia da dissecção, número de artérias afetadas e fluxo coronário distal. Como no caso relatado, em pacientes estáveis, com dissecções bem delimitadas e, sobremodo, quando o fluxo coronário é reestabelecido, pode-se optar por uma abordagem conservadora, em razão da alta incidência de resolução espontânea e da baixa incidência de eventos adversos a longo prazo


Spontaneous coronary dissection is a rare entity and, therefore, its etiology, pathophysiology, and treatment are not yet established. It affects mainly young women without the classic cardiovascular risk factors, commonly during the pregnancy-childbirth cycle. Several factors influence the treatment strategy, such as clinical presentation, hemodynamic status, topography, number of affected arteries, and distal coronary flow. As in the reported case, in stable patients with well-defined dissections and mainly when the coronary flow has been re-established, one can choose a conservative approach, due to the high incidence of spontaneous resolution and low incidence of long-term adverse events


Subject(s)
Humans , Female , Middle Aged , Coronary Disease/therapy , Dissection/methods , Therapeutics , Angiography/methods , Clinical Diagnosis/diagnosis , Coronary Vessels/surgery , Prognosis
13.
Rev. bras. cardiol. invasiva ; 23(1): 58-60, abr.-jun.2015. tab
Article in Portuguese | LILACS | ID: lil-782177

ABSTRACT

O objetivo deste estudo foi avaliar o grau de acurácia, precisão, correlação e concordância entre as medidas realizadas por um software de angiografia coronária quantitativa (QCA) online de calibração automática. Métodos: Estudo piloto que analisou imagens angiográficas de dez pacientes com um software de QCA online nas calibrações automáticas Auto ISO (calibração automática do isocentro) e Auto TOD (Table-to Object Distance). Foi realizada a medida do calibre do cateter pelos dois métodos, e o diâmetro de referência foi computado. Essas medidas foram comparadas com a medida do diâmetro do cateter quanto à acurácia, precisão e concordância. Resultados: O diâmetro médio real dos cateteres era de 1,75 ± 0,32 mm (variando entre 1,33 e 2,67 mm). A aferição dos cateteres pela QCA TOD e pela QCA ISO resultou em diâmetros médios de 1,78 ± 0,37 mm e 1,88 ± 0,38 mm, respectivamente. A acurácia/precisão da QCA TOD e da QCA ISO foi 0,03 m/0,21 mm e 0,12 mm/0,20 mm, respectivamente. As medidas da QCA TOD e da QCA ISO estiveram entre os limites de concordância em 96,3 e 94,7% dos casos, respectivamente. As medidas da QCA TOD e da QCA ISO correlacionaram-se significativamente (rs = 0,93; p < 0,01). No entanto, apesar da pequena diferença entre os métodos (0,10 ± 0,10 mm), as medidas da QCA ISO foram estatisticamente maiores que aquelas obtidas com a QCA TOD (p < 0,01). Conclusões: A QCA online com calibração automática apresentou boa acurácia, precisão e correlação,podendo representar uma ferramenta promissora no laboratório de hemodinâmica...


The objective of this study was to evaluate the degree of accuracy, precision, correlation, andagreement between the measurements performed by online Quantitative Coronary Angiography (QCA)software with automatic calibration.Methods: Pilot study that analyzed angiographic images of ten patients through online QCA softwareusing Auto ISO (automatic calibration isocenter) and Auto TOD (Table-to-Object Distance) automatic calibration. Catheter size was measured by both methods and the reference diameter was computed. These measurements were compared with the measurement of catheter diameter regarding accuracy, precision,and agreement. Results: The actual average of the catheter diameter was 1.75 ± 0.32 mm (range 1.33 to 2.67 mm). The measurement of catheters by TOD QCA and ISO QCA resulted in mean diameters of 1.78 ± 0.37 mm and 1.88± 0.38 mm, respectively. The accuracy/precision of the TOD QCA and the ISO QCA was 0.03 mm/0.21 mmand 0.12 mm/0.20 mm, respectively. The TOD QCA and ISO QCA measures were among the limits ofagreement in 96.3 and 94.7% of cases, respectively, and were significantly correlated (rs = 0.93, p < 0.01). However, despite the small difference between the methods (0.10 ± 0.10 mm), the ISO QCA measures were significantly higher than those obtained by the TOD QCA (p < 0.01). Conclusions: Online QCA with automatic calibration has good accuracy, precision, and correlation, which may represent a promising tool in the catheterization laboratory...


Subject(s)
Humans , Male , Female , Coronary Angiography/methods , Dimensional Measurement Accuracy , Coronary Disease/diagnosis , Coronary Disease/therapy , Catheters , Pilot Projects , Statistical Analysis , Stents
14.
Int. j. cardiovasc. sci. (Impr.) ; 28(2): 160-162, mar.-abr. 2015.
Article in English, Portuguese | LILACS | ID: lil-762458

ABSTRACT

Apesar dos avanços de todas as formas de tratamento da doença arterial coronariana (DAC) estável, ainda háconsiderável controvérsia sobre as vantagens da revascularização miocárdica em comparação com o tratamento clínico (TC) contemporâneo. Na DAC multiarterial, os ensaios clínicos randomizados demonstraram que astécnicas de revascularização não reduziram a incidência de desfechos duros, como morte e infarto agudo domiocárdio não fatal. Desse modo, esses estudos sugerem que o TC, tratamento de menor custo, possa ser aplicadocomo terapia inicial nesses pacientes.


Despite the advances of all forms of treatment of stable coronary artery disease (CAD), there is still considerable controversy about the benefits of myocardial revascularization compared with medical therapy (CT). In multivessel CAD, randomized clinicaltrials have demonstrated that revascularization techniques did not reduce the incidence of hard outcomes, such as death and acute nonfatal myocardial infarction. Thus, these studies suggest that CT, lower cost treatment, may be applied as initial therapy for these patients.


Subject(s)
Humans , Coronary Disease/therapy , Myocardial Revascularization , Therapeutic Approaches , Drug-Eluting Stents , Ventricular Dysfunction, Left/diagnosis , Ventricular Dysfunction, Left/therapy , Percutaneous Coronary Intervention/methods , Stents
15.
Rev. bras. cardiol. invasiva ; 23(1): 28-37, abr.-jun.2015. ilus, tab
Article in Portuguese | SES-SP, LILACS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: lil-782172

ABSTRACT

No estudo BIOACTIVE, avaliamos as respostas vasculares após implante do stent eluidor de biolimus A9 (SEB; BioMatrix®) e o stent eluidor de everolimus (SEE; XIENCE V®). Apresentamos a análise detomografia de coerência óptica (OCT) 6 meses pós-intervenção. Métodos: Os pacientes foram randomizados para tratamento com SEB (n = 22) ou SEE (n = 18). O desfecho primário foi a frequência de hastes não cobertas e mal apostas pela OCT. Resultados: A OCT foi realizada em 26 pacientes (SEB: n = 15; SEE: n = 11) e foram analisadas 749 imagens tomográficas e 7.725 hastes de stent. SEB e SEE apresentaram áreas luminais e dos stents semelhantes.A área de hiperplasia neointimal, a espessura neointimal e o porcentual de obstrução intra-stent (8,44 ± 5,10% vs. 9,21 ± 6,36%; p = 0,74) foram similares. As taxas de hastes não cobertas (SEB: 2,10 ± 3,60% vs. SEE: 2,46 ± 2,15%; p = 0,77) e mal apostas (SEB: 0,48 ± 1,48% vs. SEE 0,44 ± 1,05%; p = 0,94) foram baixas e semelhantes. A frequência de frames com sinais compatíveis com infiltrado inflamatório peri-haste foi baixa e similar entre SEB (15,53 ± 20,77%) e SEE (11,70 ± 27,51%; p = 0,68).Conclusões: Stents farmacológicos de segunda geração SEB e SEE se mostraram igualmente eficientes emsuprimir a formação neointimal aos 6 meses, com respostas vasculares favoráveis. A frequência de framescom sinais de infiltrado peri-haste por paciente foi baixa, e menor do que a historicamente observada comos stents farmacológicos de primeira geração...


In BIOACTIVE study, we evaluated vascular responses after the implant of biolimus A9-eluting stent (BES; BioMatrixTM) and the everolimus-eluting stent (EES; XIENCE VTM). In this study, we present the optical coherence tomography analysis (OCT) 6 months post-intervention. Methods: Patients were randomized to treatment with BES (n = 22) or EES (n = 18). The primary outcome was the frequency of non-covered, poorly positioned struts by OCT.Results: OCT was performed in 26 patients (BES: n = 15; EES: n = 11) and 749 tomographic images and 7,725stent struts were analyzed. BES and EES showed similar luminal and stent areas. Neointimal hyperplasia area, neointimal thickness and the percentage of in-stent obstruction (8.44 ± 5.10% vs. 9.21 ± 6.36%; p = 0.74) were similar. The rates of not covered struts (BES: 2.10 ± 3.60% vs. ESS: 2.46 ± 2.15%, p = 0.77) and poorly positioned struts (BES: 0.48 ± 1.48% vs. EES 0.44 ± 1.05%, p = 0.94) were similarly low. The frequency of frames with signs consistent with peri-strut inflammatory infiltrate was low and similar between BES (15.53 ± 20.77%) and EES (11.70 ± 27.51%; p = 0.68). Conclusions: The second-generation drug-eluting stents BES and EES were equally effective at suppressing the neointimal formation after 6 months, with favorable vascular responses. The frequency of frameswith peri-strut infiltrate signals per patient was low, and lower than that observed historically with firstgenerationdrug-eluting stents...


Subject(s)
Humans , Male , Female , Middle Aged , Coronary Disease/physiopathology , Coronary Disease/therapy , Drug-Eluting Stents , Tomography, Optical Coherence/methods , Statistical Analysis , Prospective Studies , Percutaneous Coronary Intervention/methods , Polymers/therapeutic use , Treatment Outcome , Thrombosis/complications , Thrombosis/diagnosis
16.
Rev. bras. cir. cardiovasc ; 30(1): 119-126, Jan-Mar/2015. tab, graf
Article in English | SES-SP, LILACS, SES-SP | ID: lil-742903

ABSTRACT

Objective: To evaluate the behavior of castor oil-derived polyurethane as a hemostatic agent and tissue response after abdominal aortic injury and to compare it with 2-octyl-cyanoacrylate. Methods: Twenty-four Guinea Pigs were randomly divided into three groups of eight animals (I, II, and III). The infrarenal abdominal aorta was dissected, clamped proximally and distally to the vascular puncture site. In group I (control), hemostasis was achieved with digital pressure; in group II (polyurethane) castor oil-derived polyurethane was applied, and in group III (cyanoacrylate), 2-octyl-cyanoacrylate was used. Group II was subdivided into IIA and IIB according to the time of preparation of the hemostatic agent. Results: Mean blood loss in groups IIA, IIB and III was 0.002 grams (g), 0.008 g, and 0.170 g, with standard deviation of 0.005 g, 0.005 g, and 0.424 g, respectively (P=0.069). The drying time for cyanoacrylate averaged 81.5 seconds (s) (standard deviation: 51.5 seconds) and 126.1 s (standard deviation: 23.0 s) for polyurethane B (P=0.046). However, there was a trend (P=0.069) for cyanoacrylate to dry more slowly than polyurethane A (mean: 40.5 s; SD: 8.6 s). Furthermore, polyurethane A had a shorter drying time than polyurethane B (P=0.003), mean IIA of 40.5 s (standard deviation: 8.6 s). In group III, 100% of the animals had mild/severe fibrosis, while in group II only 12.5% showed this degree of fibrosis (P=0.001). Conclusion: Polyurethane derived from castor oil showed similar hemostatic behavior to octyl-2-cyanoacrylate. There was less perivascular tissue response with polyurethane when compared with cyanoacrylate. .


Objetivo: Avaliar o comportamento hemostático e a reação tecidual do poliuretano, derivado da mamona, após injúria da aorta abdominal de cobaias e compará-lo com o 2-octil-cianoacrilato. Métodos: Vinte e quatro cobaias foram divididas aleatoriamente em três grupos de oito animais (I, II e III). A aorta abdominal infrarrenal foi dissecada, pinçada proximal e distalmente ao local que se procedeu à punção vascular. No grupo I (controle), a hemostasia foi feita com digitopressão; no grupo II (poliuretano), aplicou-se o selante vegetal e, no grupo III (cianoacrilato), aplicou-se o 2-octil-cianoacrilato. O grupo II foi subdividido em IIA e IIB, conforme o tempo de preparo do poliuretano. Resultados: A média de perda sanguínea nos grupos IIA, IIB e III foi 0,002 g, 0,008 g e 0,170 g, com desvios padrões de 0,005 g, 0,005 g e 0,424 g, respectivamente (P=0,069). O tempo de secagem do selante cianoacrilato foi em média 81,5 segundos (s) (desvio padrão: 51,5 s), enquanto o poliuretano B levou 126,1 segundos (desvio padrão: 23,0 s) (P=0,046). Entretanto, houve tendência (P=0,069) do cianoacrilato apresentar um tempo maior de secagem que o poliuretano A. Além disso, o poliuretano A teve um tempo de secagem menor que o poliuretano B (P=0,003), com média para o IIA de 40,5 segundos (desvio padrão: 8,6 s). No grupo III, 100% dos animais tiveram fibrose moderada/acentuada, enquanto no grupo II apenas 12,5% (P=0,001). Conclusão: O poliuretano derivado da mamona apresentou comportamento hemostático semelhante ao 2-octil-cianoacrilato. A cola vegetal demonstrou menor reação tecidual perivascular. .


Subject(s)
Humans , Coronary Disease/complications , Depression/complications , Primary Health Care , Case Management , Cohort Studies , Coronary Disease/therapy , Depression/therapy , Feasibility Studies , United Kingdom , Patients/psychology , Perception , Physicians, Primary Care/psychology , Qualitative Research , Research Design
17.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 24(1): 17-22, jan.-mar. 2014. tab
Article in Portuguese | LILACS | ID: lil-729289

ABSTRACT

O tratamento da doença coronária crônica visa garantir qualidade de vida e impedir a morte. O tratamento medicamentoso baseado em antiagregantes plaquetários e medidas de prevenção secundária são mandatórios nesses pacientes. Entretanto, alguns pacientes selecionados também se beneficiam de procedimentos de intervenção coronária, seja percutânea (ICP) ou cirúrgica (RM). A decisão pela intervenção e que tipo de intervenção é baseada em análise individualizada, levando-se em conta fatores como grau de angina, função ventricular, carga isquêmica e anatomia coronária. Pacientes com doença coronária multiarterial com disfunção ventricular ou grandes áreas de isquemia geralmente se beneficiam da cirurgia de revascularização do miocárdio, assim como aqueles com obstrução do tronco da coronária esquerda. Em pacientes bi ou triarterial sem diabetes ou disfunção ventricular importante, tanto ICP como RM podem ser indicadas, conforme características individuais. Os procedimentos de revascularização não estão indicados nos portadores de obstruções coronárias não significativas, uni ou biarteriais sem acometimento proximal da artéria descendente anterior, sem isquemia documentada e com função ventricular preservada.


The treatment of chronic coronary disease aims to ensure quality of life and prevent death. Drug treatment based on antiplatelet therapy and secondary prevention measures are mandatory in these patients. However, some selected patients also benefit from coronary intervention procedures, whether percutaneous (PCT) or surgical (CABG). The decision for the intervention and what kind of intervention is based on individual analysis considering factors such as degree of angina, ventricular function, ischemic burden and coronary anatomy. Patients with multi-coronary artery disease with left ventricular dysfunction or large áreas of ischemia usually benefit from coronary artery by-pass grafting, as well as those with obstruction of the left main coronary artery. In two-or three-vessel disease patients without diabetes or severe ventricular dysfunction either PCI or CABG can be indicated according to individual characteristics. Revascularization procedires are not indicated in patients with no significant coronary obstructions, one or two-vesel disease without involvement of proximal left anterior descending artery, without documented ischemia and preserved ventricular function.


Subject(s)
Humans , Male , Female , Coronary Disease/therapy , Percutaneous Coronary Intervention/methods , Drug Therapy , Myocardial Revascularization/methods , Chronic Disease , Coronary Stenosis , Risk Factors , Guidelines as Topic/standards , Prognosis , Drug Utilization
18.
JNE-Journal of Nursing Education. 2014; 3 (2): 12-26
in Persian | IMEMR | ID: emr-149058

ABSTRACT

Learning is the core of human identity showing social participation. Socio-cultural factors have a great impact on learning experiences of new nurses in critical coronary care units [CCCU]. The aim of this study was to explore new nurses' clinical learning experience in the critical coronary care units" [CCCU]. In this qualitative study we used purposive sampling with maximum variation. We interviewed 18 participants with open-ended questions from 2012 to 2013 in Semnan, Iran. The main method of data collection was semi-structured interviews. The interviews were recorded digitally and immediately transcribed and then analyzed by conventional content analysis method. Based on the data analysis, we extracted four themes which indicated clinical learning experiences of new nurses in the CCCU. The themes included "challenges of basic education", "self-directed learning", "equal protection" and "effective supervision". These themes were influenced by the environment and the nurse's role in clinical learning experiences. The main theme was "situational learning". The new nurses learned clinical experience by combining themes in CCCU. The results of this study are valuable for the recognition of learning strategy in the area of knowledge, attitude and practice of new nurses in CCCU. Based on the results of this study, nurse managers, supervisors and trainers can improve nursing education by motivation of personal learning; creating supportive environments and enhanced supervision to provide better clinical learning for new nurses entering CCCU


Subject(s)
Humans , Female , Male , Education, Nursing/standards , Clinical Competence , Milieu Therapy/education , Coronary Disease/therapy , Health Knowledge, Attitudes, Practice , Cardiovascular Nursing , Coronary Care Units
19.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 23(4): 40-44, out.-dez.2013.
Article in Portuguese | LILACS | ID: lil-742383

ABSTRACT

o benefício em longo prazo do tratamento com estatinas naprevenção de eventos coronarianos primários e secundários éindiscutível. Embora uma parte deste benefício esteja ligadaao efeito sobre a redução da circulação de lipoproteínasaterogênicas, outros mecanismos, como a modulação datrombogênese, a redução da inflamação e melhora da funçãoendotelial, têm sido investigados. O efeito da estatina sobrea função endotelial está ligado à sua inibição da produçãode superóxido e sua regulação positiva da síntese do óxidonítrico (NOS) no endotélio. Na prática clínica, o benefíciona função do endotélio depois do tratamento com estatinatem sido observado em uma ampla variedade de condiçõesque incluem a hipertensão arterial sistêmica, doença arterialcrônica e síndrome coronariana aguda. Esta breve revisãoincidirá sobre as principais conclusões relacionadas à terapiacom estatina sobre o tônus arterial sistêmico e doença arterialcoronariana aguda e crônica...


The long-term benefit of statin treatment on the prevention of primary and secondary coronary events is undisputed. Although a proportion of this effect has been linked to its reduction of circulating atherogenic lipoproteins, other mechanisms have been studied such as modulation of thrombogenesis, reduction of inflammation, and improvement of endothelia! function. Its favorable effect on endothelial function is tied to its inhibition of superoxide production and its positive regulation of nitric oxide synthase (NOS) in the endothelium. In the clinica! setting, the gain in endothelia! function after statin treatment has been observed in a wide range of conditions that include systernic hypertension, chronic arterial disease, and acute coronary syndrome. This brief review will focus on the main findings related to statin therapy on the systernic arterial tone and both acute and chronic coronary artery disease...


Subject(s)
Humans , Coronary Disease/therapy , Endothelium/chemistry , Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry , Exercise Test , Pravastatin/administration & dosage , Simvastatin/administration & dosage
20.
J. bras. med ; 101(4): 7-12, jul.-ago. 2013.
Article in Portuguese | LILACS | ID: lil-699658

ABSTRACT

Neste artigo revisaremos o tratamento antiplaquetário e antilipêmico, controle da pressão arterial e controle da frequência cardíaca e sua influência na mortalidade e novos eventos, aplicável a todo paciente portador de doença coronariana crônica.


We review the antiplatelet and hypolipidemic treatment, blood pressure and heart rate control and its influence on mortality and new events, applicable to all patients with chronic coronary disease.


Subject(s)
Humans , Male , Female , Coronary Disease/therapy , Hypolipidemic Agents/administration & dosage , Hypolipidemic Agents/therapeutic use , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/therapeutic use , Clofibric Acid/therapeutic use , Aspirin/administration & dosage , Diet, Fat-Restricted , Drug Interactions , Heart Rate , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Life Style , Arterial Pressure
SELECTION OF CITATIONS
SEARCH DETAIL